Drug lookup
Drug reference

clavulanic acid

Beta-lactamase inhibitor · Enzyme inhibitor

Beta-lactamase inhibitorEnzyme inhibitor
CDSCO approved
EXCRETION
not curated
INTERACTIONS
5 major
SEVERE in our sources
PREGNANCY
not curated
Top interactionssee all 6
  • LeflunomideSevereDatabaseDDInter
  • LomitapideSevereDatabaseDDInter
  • MipomersenSevereDatabaseDDInter
  • PexidartinibSevereDatabaseDDInter

Mechanism

Clavulanic acid has a β-lactam ring but no antibacterial activity of its own. It inhibits a wide variety of β-lactamases (class II to class V, but not class I cephalosporinase) produced by both gram-positive and gram-negative bacteria. It is a 'progressive' or 'suicide' inhibitor, binding reversibly initially and then covalently to β-lactamase, leading to its inactivation. It permeates the outer layers of the cell wall of gram-negative bacteria and inhibits the periplasmically located β-lactamase.

Pharmacokinetics

Half-life
1 hr
Bioavailability
60%
Protein binding
tissue distribution matches amoxicillin
Metabolism
largely hydrolysed and decarboxylated before excretion

Drug interactions

Leflunomide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Lomitapide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Mipomersen
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Pexidartinib
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Teriflunomide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amoxicillin
Moderate
Textbook

Effective against β-lactamase producing H. influenzae, N. gonorrhoeae and other organisms.

Source: KDT 7e · p698

6 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Beta-lactamase inhibitor drugs

Ask House about clavulanic acid

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team